2 completed, 1 withdrawn. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Sodium Channel Blockers: new trials by email Literature Review of Sodium Channel Blockers trials Research Report on Sodium Channel Blockers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure Potassium sparing diuretic - Heart Failure, Heart Failure With Reduced Ejection Fraction | Completed | Alexandria University | 100 | 2022-10-15 | 2024-02-26 | |
| Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism Teriparatide, Thiazide, Potassium sparing diuretic - Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2017-06-06 | 2021-06-28 |
| High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure Spironolactone - Heart Failure | Phase 4 | Withdrawn | The University of Texas Health Science Center at San Antonio | 2014-05-01 | 2016-04-20 |
Heart Failure (2) · Coitus (1) · Hypercalciuria (1) · Hypoparathyroidism (1)
Alexandria University (1) · Assistance Publique - Hôpitaux de Paris (1) · The University of Texas Health Science Center at San Antonio (1)
Egypt (1) · France (1) · United States (1)
Agnes Linglart, MD, PhD (1) · Anne Blanchard, MD, PhD (1) · Marvin H Eng, M.D. (1) · Salah Abdelkader, MSc (1)
2016 (1)